By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Has a Good Idea; Doctors Object
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > FDA Has a Good Idea; Doctors Object
BusinessNewsPublic Health

FDA Has a Good Idea; Doctors Object

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The idea: In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The idea: In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The Doctors’ Objection: “What the government via the FDA has decided to do is just bypass the expensive doctor and to satisfy some safety concerns of letting people just pick out their medications is make sure they have to get counsel by the pharmacists,” Dr. Mintz [an internist at George Washington University Hospital] said. “I believe there is value to using pharmacists, but not at the expense of primary care.”

The Pharmacists Counter: “We think it’s a great development for everybody — for pharmacists, for patients and the whole health care system,” said Brian Gallagher, a lobbyist for the American Pharmacists Association. “The way we look at it is there are a lot of people out there with chronic conditions that are undertreated and this would enable the pharmacists to redirect these undertreated people back into the health care system.”

More Read

June 23-24 OneMedForum New York
Elad Anter Explains New Technologies in Catheter Ablation for Atrial Fibrillation
The PCMH and Home Care Data: An Interview with Melissa McCormack
Generating Press Release Ideas for Your Medical Practice
Dr. Ryan Shelton Reveals 9 Data-Driven Tips for Optimal Health

More from Paige Winfield Cunningham in the Washington Times.

  

TAGGED:FDApharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Veneers vs. Crowns vs. Bonding: Understanding Cosmetic Options
Veneers vs. Crowns vs. Bonding: Understanding Cosmetic Options
Dental health Specialties
June 23, 2026
dental implants
Dental Implants and Quality of Life: What the Outcomes Data Shows
Dental health Specialties
June 23, 2026
Why Outpatient Addiction Treatment Works Better Than Most People Expect
Addiction Addiction Recovery
June 20, 2026
grief affects brain
How Grief Affects The Brain And Body
Infographics Mental Health
June 19, 2026

You Might also Like

Wanted: Entrepreneurial Business Models for Doctors

May 19, 2013
down-trend
BusinessHospital Administration

9 Ways to Kill Your Physician Liaison Program Before It Begins

April 23, 2014

Evidence Based Care Coordination CAN Work in Medicare

February 1, 2012
Clinical trial data
BusinesseHealthFinanceMedical Records

Clinical Trials Software Firm Gets Funding to Help with Health Data Digitization

November 4, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?